CIGB-300 (P15-Tat)
Anti-CK2 cyclic cell-penetrating research peptide.
Oncology Research Peptides
GF9 is a synthetic 9-amino-acid ligand-independent immunomodulatory peptide designed via the Signaling Chain Homooligomerization (SCHOOL) model to target mouse TREM-1. It is studied as a research reagent for TREM-1/DAP-12 signal-disruption research, pro-inflammatory cytokine-modulation studies relevant to systemic inflammation and sepsis research, tumor-model research in non-small-cell-lung-cancer xenografts, and pathological-neovascularization research.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Anti-CK2 cyclic cell-penetrating research peptide.
Telomerase-derived 16-mer research peptide.
PSP-94-derived antitumor research peptide.